Pet Drug Market
Pet Drug Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Pet Drug Market Size and Growth
The pet drug market is experiencing significant growth, driven by increasing pet ownership and rising expenditure on pet healthcare. Valued at approximately $14.5 billion in 2023, the market is projected to expand due to innovations in pharmaceuticals and a shift towards preventive care, enhancing overall pet health management.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Zoetis
◍ Boehringer Ingelheim
◍ Merck Animal Health
◍ Elanco Animal Health
◍ Virbac
◍ Dechra Veterinary Products
◍ Ceva
◍ Vetoquinol
◍ Meiji
◍ Ouro Fino Saude
◍ Parnell
The pet drug market features companies like Zoetis, Boehringer Ingelheim, and Merck Animal Health, focusing on innovative treatments and preventive care. Their investments in R&D and expanding product portfolios drive market growth. Revenue highlights include Zoetis at approximately $7.8 billion and Merck Animal Health around $4 billion.
Request Sample Report
Market Segmentation
By Application
Dogs
Cats
Other
Request Sample Report
By Product
Antiparasitic Drugs
Antibacterial
Other
$ 99.80 Billion
Request Sample Report
